Navigation Links
Drug Refused to Asbestos-Linked Cancer Patients

A body that is responsible for approving NHS treatments has been accused of placing money before patients//, after it blocked the usage of an anti-cancer drug.

The group analyzed the cost effectiveness of the drug, used to treat the cancer mesothelioma, and concluded that the drug would not be recommended for use except as part of ongoing or new.trial.

Mesothelioma is a kind of cancer that affects the lung lining and nine out of ten cases are due to exposure to asbestos. People who are involved in shipbuilding, railway engineering and asbestos product manufacturing are at an increased risk. . A cure for the disease is not available and pemetrexed disodium treatment is used to maintain the quality of life.

The makers of the drug, Eli Lilly, said it will appeal against the decision. Medical director of Lilly UK, Dr Joanna Nakielny, said: "This is a major blow for patients with mesothelioma, many of whom were unwittingly exposed to asbestos in their working lives making submarines, ships, boilers and trains”.

"This treatment does not save lives, but it can prolong the lives of patients and also improve the quality of the time they have left. Lilly will be formally appealing NICE’s decision." She added.


'"/>




Page: 1

Related medicine news :

1. Smoker Refused Treatment
2. Boy Refused Compensation For HIV Infection Following Hospital Admission
3. One in Ten NHS Dentists Refused To Sign the New Contract
4. Gardasil Refused Subsidy
5. NRI Fights for HIV Child Who was Refused Treatment
6. Fibroids unlikely to Turn Cancerous
7. Virus Level could Predict Cervical Cancer Risk
8. Cancer Doctors Okays Controversial Prostate Therapy
9. Potential New Cancer Gene Identified
10. Consensus on "Combination Therapy" for Breast Cancer
11. Cancers of Colon & Rectum linked to Cigarette Smoking
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/20/2017)... , ... June 20, 2017 , ... Uniform Advantage ... collection featuring seven new products designed to create tailored looks and athleisure-inspired outfits. UA ... and cotton easy care stretch twill. , With trendy looks hitting the medical community, ...
(Date:6/20/2017)... ... June 20, 2017 , ... John D'Eri, CEO of ... Leader in Adult Autism Award during the Autism Society of America 's ... The Daniel Jordan Fiddle Foundation (DJFF) was founded in 2002 as the ...
(Date:6/20/2017)... ... 20, 2017 , ... International water advocate Sharon Kleyne is ... Power of Water, Global Climate Change and Your Health on VoiceAmerica sponsored by ... how it affects the human eyes. , According to Sharon Kleyne and ...
(Date:6/20/2017)... Chevy Chase, MD (PRWEB) , ... June 20, 2017 , ... ... across the nation, the Society of Professional Benefit Administrators (SPBA) has provided input to ... letter with Sens. Mitch McConnell (R - KY), Charles E. Schumer (D - ...
(Date:6/19/2017)... ... June 19, 2017 , ... Intrinsic Clinical ... the international exchange of actionable insights to improve health globally through the advancement ... make clinical trial management faster, easier, and less painful. Attendees can visit Intrinsic’s ...
Breaking Medicine News(10 mins):
(Date:6/16/2017)... 50 years ago today, the Monterey Pop Festival opened its ... San Francisco "Summer of Love."  To celebrate the anniversary, Northern ... strategic market research portals that it will begin delivering to ... Light,s "Summer of Love (For Our Customers)."  ... Northern ...
(Date:6/14/2017)... -- In 2016, Embodied Labs took top prize ... came away with $25,000 in seed-fund investment. Embodied Labs ... "entering the life of another" and by the Journal ... medical professionals in an entirely new dimension." Building upon ... for the Department of Education,s EdSimChallenge, where they received ...
(Date:6/11/2017)... June 10, 2017  Eli Lilly and Company (NYSE: ... Phase 3 studies of galcanezumab, an investigational treatment for ... data on several key secondary endpoints for galcanezumab compared ... these studies (EVOLVE-1, EVOLVE-2 and REGAIN) will be presented ... meeting in Boston . ...
Breaking Medicine Technology: